The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 Charles Clark - Abstracts

The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 Charles Clark
TitleSubjectAuthors
Allscripts H'care.(stock price appreciation potential of Allscripts Healthcare Solutions, Inc.)Business, generalCharles Clark
ANSYS, Inc.(stock price appreciation potential)(Analyst report)Business, generalCharles Clark
Barrick Gold.(stock price appreciation potential)Business, generalCharles Clark
Biotechnology industry.(analysis of securities)Business, generalGeorge Rho, Charles Clark, Keith A. Markey, Randy Shrikishun, Andre J. Costanza, Susan J. Ferrara, Jerry W. Gray, John D. Burke
Biotechnology industry.(analysis of securities)Business, generalGeorge Rho, Charles Clark, Keith A. Markey, Randy Shrikishun, Andre J. Costanza, Susan J. Ferrara, Jerry W. Gray, Nira Maharaj
Block (H&R).(stock price appreciation potential)(Analyst report)Business, generalCharles Clark
Block (H&R).(stock price appreciation potential; H&R Block Inc.)Business, generalCharles Clark
BMC Software.(stock price appreciation potential)(Analyst report)Business, generalCharles Clark
Cerner Corp.(stock price appreciation potential)Business, generalCharles Clark
Chemical (specialty).(analysis of securities)Business, generalCharles Clark, Jeremy J. Butler, Adam Rosner, Frederick L. Harris, Simon R. Shoucair, Jason A. Smith, Lester Ratcliff, Ian Gendler, Erik A. Antonson, Bryan Fong
Computer software and services.(analysis of securities)Business, generalGeorge A. Niemond, Charles Clark, Adam Rosner, Randy Shrikishun, Lester Ratcliff, Douglas Maurer, Erik A. Manning
Computer software and services.(analysis of securities)Business, generalWarren Thorpe, Theresa Brophy, George A. Niemond, Charles Clark, Adam Rosner, Erik M. Manning, Randy Shrikishun, Frederick L. Harris, Lester Ratcliff, Michael F. Napoli
Drug industry.Business, generalGeorge Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer
Drug industry.(analysis of securities)Business, generalGeorge Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, Frederick L. Harris, Susan J. Ferrara, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer
Drug industry.(securities analysis as of July 20, 2007)(Industry overview)Business, generalGeorge Rho, Mario Ferro, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, William C. Lewittes
Eclipsys Corp.(stock price appreciation potential)Business, generalCharles Clark
Financial services (diversified).(analysis of securities)Business, generalWarren Thorpe, Charles Clark, Adam Rosner, Erik M. Manning, George Y. Lee, Randy Shrikishun, Frederick L. Harris, Lester Ratcliff, Ian Gendler, Michael F. Napoli, Douglas G. Maurer, Bryan Fong
Financial services (diversified).(securities' analysis)Business, generalWarren Thorpe, Charles Clark, Adam Rosner, Erik M. Manning, George Y. Lee, Randy Shrikishun, Frederick L. Harris, Lester Ratcliff, Ian Gendler, Michael F. Napoli, Douglas G. Maurer, Enzo DiCostanzo, Bryan Fong
Healthcare info. services.(analysis of securities)Business, generalCharles Clark, Randy Shrikishun, Andre J. Costanza
Healthcare info. services.(stock price appreciaion potential of the health care information services industry)Business, generalCharles Clark
Helathcare info. Services.(analysis of securities)Business, generalCharles Clark, Randy Shrikishun, Andre J. Costanza
HLTH Corp.(stock price appreciation potential)Business, generalCharles Clark
IMS Health.(stock price appreciation potential)Business, generalCharles Clark
Internet industry.(analysis of securities)Business, generalWarren Thorpe, Charles Clark, George Y. Lee, Ian Gendler, Michael F. Napoli, Sharif Abdou, Mathew E. Spencer
Internet industry.(securities' analysis)Business, generalWarren Thorpe, Charles Clark, George Y. Lee, Randy Shrikishun, Ian Gendler, Michael F. Napoli, Sharif Abdou, Enzo Dicostanzo
inVentiv Health, Inc.(stock price appreciation potential)Business, generalCharles Clark
Newmont Mining.(stock price appreciation potential)Business, generalCharles Clark
Onyx Pharmac.(stock price appreciation potential; Onyx Pharmaceuticals Inc.)Business, generalCharles Clark
Precious metals.Business, generalSigourney B. Romaine, Charles Clark, Michael F. Napoli, Dominic B. Silva, Douglas G. Maurer, Fredirick L. Harris
Precious metals.(analysis of securities)Business, generalSigourney B. Romaine, Charles Clark, Frederick L. Harris, Michael F. Napoli, Dominic B. Silva, Douglas G. Maurer
Precious metals industry.(securities analysis as of July 20, 2007)(Industry overview)Business, generalCharles Clark, Stuart Plesser, Frederick L. Harris, William C. Lewittes
Precious metals.(stock price appreciation potential)Business, generalCharles Clark
RealNetworks, Inc.(stock price appreciation potential)Business, generalCharles Clark
RealNetworks, Inc.(stock price appreciation potential)(Analyst report)Business, generalCharles Clark
Regeneron Pharm.(stock price appreciation potential of Regeneron Pharmaceuticals, Inc.)Business, generalCharles Clark
Sybase, Inc.(stock price appreciation potential)Business, generalCharles Clark
Sybase Inc.(stock price appreciation potential)(Analyst report)Business, generalCharles Clark
Symantec Corp.(stock price appreciation potential)Business, generalCharles Clark
Symantec Corp.(stock price appreciation potential)(Analyst report)Business, generalCharles Clark
Symyx Tech. Inc.(stock price appreciation potential)(Symyx Technologies Inc.)(Analyst report)Business, generalCharles Clark
Symyx Tech. Inc.(Symyx Technologies, Inc.)(stock price appreciation potential)Business, generalCharles Clark
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.